Value-Based Cancer Care Issues

March 2013, Vol 4, No 3

Evaluating Payer Restrictions on Prostate Cancer Treatments

Melinda C. Haren; Kati Sadiwnyk; Joseph Tucciarone

AVBCC 2013 3rd Annual Conference Abstracts

Background: According to the National Institutes of Health, medical expenditures are projected to reach $158 billion by the year 2020. This represents a 27% increase from 2010 costs. Prostate cancer is in the top 5 contributors of this cost, and is projected to reach $12 billion. Advancements in drugs, surgery, and radiation therapy have all contributed to an increase in costs. Payers are feeling increased pressure to make cost-effective choices among these agents.

[ Read More ]